Assignee
MEDREGEN LLC
US·5 granted patents·5 pending applications·8 citations·filing 2014–2024
Top patents by PatentIndex Score
10 records- 0189US11291657B2Methods of treating inflammatory bowel disease with AMD3100 and TacrolimusMEDREGEN LLC·Filed 2019·Granted Apr 5, 2022·3 cites·5 claims
- 0285US10420751B2Methods of treating inflammatory bowel disease with AMD3100 and tacrolimusMEDREGEN LLC·Filed 2015·Granted Sep 24, 2019·5 cites·2 claims
- 0375US2022184043A1Methods of treating inflammatory bowel disease with amd3100 and tacrolimusMEDREGEN LLC·Filed 2022·Application pending·0 cites
- 0470US2023255931A1Pharmaceutical compositions useful for the treatment of tissue injuryMEDREGEN LLC·Filed 2023·Application pending·0 cites
- 0570US2021008042A1Treatment methods utilizing stem cell mobilizers and immunosuppressive agentsMEDREGEN LLC·Filed 2020·Application pending·0 cites
- 0667US12048687B2Methods of recruiting SDF-producing macrophagesMEDREGEN LLC·Filed 2021·Granted Jul 30, 2024·0 cites·15 claims
- 0766US12115149B2Formulations, methods, kits, and dosage formsMEDREGEN LLC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0866US10945993B2Methods of recruiting SDF-producing macrophagesMEDREGEN LLC·Filed 2014·Granted Mar 16, 2021·0 cites·12 claims
- 0963US2025017912A1Methods for down-regulation and up-regulation of pathwaysMEDREGEN LLC·Filed 2024·Application pending·0 cites
- 1043US2018200232A1Pharmaceutical compositions useful for the treatement of tissue injuryMEDREGEN LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →